Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 7/20 | 0.46 |
| ▸ | NPC1 | O15118 | 6/20 | 0.46 |
| ▸ | RAB9A | P51151 | 5/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1584021 | 0.98 | CA1 (0.48) | CA1CA2CA9LMNANPC1 | |
| Bromide SCHEMBL20984343 | 0.98 | CA1 (0.48) | CA1CA2CA9LMNANPC1 | |
| Hydrochloric Acid SCHEMBL29788704 | 0.98 | CA1 (0.48) | CA1CA2CA9LMNANPC1 | |
| Oxalic Acid SCHEMBL20984246 | 0.89 | LMNA (0.54) | CA1CA2CA9LMNANPC1 | |
| Phosphoric Acid SCHEMBL20984405 | 0.89 | NPC1 (0.46) | CA1CA2CA9LMNANPC1 | |
| Sulfuric Acid SCHEMBL20984763 | 0.89 | CA1 (0.54) | CA1CA2CA9LMNANPC1 | |
| Nitric Acid SCHEMBL20984844 | 0.86 | CA1 (0.47) | CA1CA2CA9LMNANPC1 | |
| SCHEMBL4668847 | 0.82 | DGAT1 (0.39) | CA1CA2CA9LMNANPC1 | |
| Hydrochloric Acid SCHEMBL3642581 | 0.80 | DGAT1 (0.38) | CA1CA2CA9LMNANPC1 | |
| SCHEMBL19267221 | 0.79 | LMNA (0.51) | CA1CA2CA9LMNANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114364668-B | CDK4/6 inhibitors, and salts and intermediates thereof | 甘李药业股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-20220315532-A1 | METHODS FOR PREPARING CDK4/6 INHIBITOR AND SALT AND INTERMEDIATE THEREOF | GAN & LEE PHARMACEUTICALS CO., LTD. (CN) | 2022-10-06 | — | — | US | claimed |
| EP-3988545-A1 | METHODS FOR PREPARING CDK4/6 INHIBITOR AND SALT AND INTERMEDIATE THEREOF | Gan & Lee Pharmaceuticals Co., Ltd. (CN) | 2022-04-27 | — | — | EP | claimed |
| CN-114364668-A | CDK4/6 inhibitors, salts and intermediates thereof | 甘李药业股份有限公司 | 2022-04-15 | — | — | CN | claimed |
| WO-2020253865-A1 | METHODS FOR PREPARING CDK4/6 INHIBITOR AND SALT AND INTERMEDIATE THEREOF | 甘李药业股份有限公司 | 2020-12-24 | — | — | WO | claimed |
| US-20250346600-A1 | TRICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS, INC. | 2025-11-13 | — | — | US | disclosed |
| WO-2025054488-A1 | TRICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS, INC. (US) | 2025-03-13 | — | — | WO | disclosed |
| WO-2024173646-A1 | CYCLIN-DEPENDENT KINASE DEGRADING COMPOUNDS | INNOVO THERAPEUTICS, INC. (US) | 2024-08-22 | — | — | WO | disclosed |
| CN-114364668-B | CDK4/6 inhibitors, and salts and intermediates thereof | 甘李药业股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| US-11787801-B2 | Protein kinase inhibitors, preparation method and medical use thereof | GAN & LEE PHARMACEUTICALS (CN) | 2023-10-17 | — | — | US | disclosed |
| US-20230219965-A1 | NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS | KSQ Therapeutics, Inc. | 2023-07-13 | — | — | US | disclosed |
| US-20230219965-A1 | NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS | KSQ Therapeutics, Inc. | 2023-07-13 | — | — | US | disclosed |
| US-5041155-A | Preemergence herbicide mixture for controlling grass; for use with soybeans, corn or sugar cane | FMC CORPORATION (US) | 1991-08-20 | — | — | US | disclosed |
| US-4818275-A | PREEMERGENCE | FMC CORPORATION (US) | 1989-04-04 | — | — | US | disclosed |
| EP-0294375-A1 | HERBICIDAL ARYL TRIAZOLINONES. | FMC CORP (US) | 1988-12-14 | — | — | EP | disclosed |
| EP-0294375-A4 | HERBICIDAL ARYL TRIAZOLINONES. | FMC CORP (US) | 1988-10-20 | — | — | EP | disclosed |
| WO-1987003782-A1 | HERBICIDAL ARYL TRIAZOLINONES | FMC CORPORATION (US) | 1987-07-02 | — | — | WO | disclosed |
| US-4448961-A | Substituted anilino pyrimidines | ZOECON CORPORATION (US) | 1984-05-15 | — | — | US | disclosed |
| US-4411839-A | α-Cyano-β-(trisubstituted phenylhydrazino)-n-ethoxycarbonylacrylamides | ZOECON CORPORATION (US) | 1983-10-25 | — | — | US | disclosed |
| US-4042373-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220315532-A1 | METHODS FOR PREPARING CDK4/6 INHIBITOR AND SALT AND INTERMEDIATE THEREOF | CDK4, CDK6, CDK8 | CA1 3604/4885CA2 2565/4885CA9 2056/4885 |
| US-11787801-B2 | Protein kinase inhibitors, preparation method and medical use thereof | ROR1, DMPK, CDK9 | CA1 2185/4885CA2 2152/4885CA9 795/4885 |
| US-20230219965-A1 | NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS | USP1, USP8, USP7 | CA1 1343/4885CA2 3915/4885CA9 3092/4885 |
| US-20250346600-A1 | TRICYCLIC DERIVATIVES AND RELATED USES | WRN, RECQL, BLM | CA1 4352/4885CA2 4248/4885CA9 4047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.